- Home
- ROLR vs LEXX Comparison
ROLR vs LEXX Comparison
Compare ROLR & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROLR
- LEXX
- Stock Information
- Founded
- ROLR 2021
- LEXX 2004
- Country
- ROLR United States
- LEXX Canada
- Employees
- ROLR N/A
- LEXX N/A
- Industry
- ROLR
- LEXX Biotechnology: Pharmaceutical Preparations
- Sector
- ROLR
- LEXX Health Care
- Exchange
- ROLR NYSE
- LEXX Nasdaq
- Market Cap
- ROLR 46.9M
- LEXX 43.5M
- IPO Year
- ROLR 2024
- LEXX N/A
- Fundamental
- Price
- ROLR $5.54
- LEXX $2.16
- Analyst Decision
- ROLR
- LEXX Strong Buy
- Analyst Count
- ROLR 0
- LEXX 2
- Target Price
- ROLR N/A
- LEXX $11.00
- AVG Volume (30 Days)
- ROLR 47.5K
- LEXX 192.0K
- Earning Date
- ROLR 12-04-2024
- LEXX 01-10-2025
- Dividend Yield
- ROLR N/A
- LEXX N/A
- EPS Growth
- ROLR N/A
- LEXX N/A
- EPS
- ROLR N/A
- LEXX N/A
- Revenue
- ROLR $27,016,690.00
- LEXX $464,278.00
- Revenue This Year
- ROLR N/A
- LEXX $73.01
- Revenue Next Year
- ROLR N/A
- LEXX $48.40
- P/E Ratio
- ROLR N/A
- LEXX N/A
- Revenue Growth
- ROLR N/A
- LEXX 105.24
- 52 Week Low
- ROLR $5.00
- LEXX $1.20
- 52 Week High
- ROLR $8.46
- LEXX $6.85
- Technical
- Relative Strength Index (RSI)
- ROLR N/A
- LEXX 41.53
- Support Level
- ROLR N/A
- LEXX $2.00
- Resistance Level
- ROLR N/A
- LEXX $2.54
- Average True Range (ATR)
- ROLR 0.00
- LEXX 0.25
- MACD
- ROLR 0.00
- LEXX -0.01
- Stochastic Oscillator
- ROLR 0.00
- LEXX 12.94
About ROLR HIGH ROLLER TECHNOLOGIES INC
High Roller Technologies Inc is a company which operates through its subsidiaries controls an online gaming operator. They offer a diverse and dynamic real money i Casino entertainment products to players worldwide through our Platform. Through their Platform we provide a large selection of exciting games, personalized experiences and a community, in a safe, secure environment, built on trust and customer service. iGaming, or online casino, offerings typically include the full suite of games available in land-based casinos, such as blackjack, roulette, baccarat, poker and slot machines.
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.